Quantcast
Last updated on April 20, 2014 at 8:14 EDT

Latest Guanidines Stories

2011-02-14 07:00:00

NEW YORK and SAN DIEGO, Feb. 14, 2011 /PRNewswire/ -- Polaris Group (Polaris) and The Ludwig Institute for Cancer Research (LICR) today announced the enrollment of the first patient in a Phase 2 clinical trial evaluating ADI-PEG 20 in the treatment of small cell lung cancer (SCLC). The trial, sponsored by LICR, is enrolling patients at Memorial Sloan-Kettering Cancer Center and Duke University Medical Center and will soon commence at St. Bartholomew's Hospital in London. This study will...

2011-02-08 00:11:45

Gilad&Gilad LLC of Reseda (Los Angeles), California, has re-launched Neurofencine(TM), a first-of-its-kind nutraceutical supplement clinically proven for nerve resilience and pain-free nerve functions. Neurofencine(TM) targets unmet needs of millions of people who cope with circumstances affecting normal nerve functions. Reseda, CA (PRWEB) February 6, 2011 Neurofencine(TM) development is the outcome of breakthrough discoveries made and patented by the neuroscientist founders of...

2010-12-21 00:01:52

NitricOxideSupplementSite.com provides users the best source of information on pre-workout supplements, also known as nitric oxide supplements. Nitric oxide supplements have been proven in research to improve fitness, strength, and even improve erectile dysfunction (ED) symptoms when used properly. Los Angeles, CA (PRWEB) December 20, 2010 Today http://www.NitricOxideSupplementSite.com was launched in an effort to provide a quality source of free information on the confusing topic of...

2010-12-21 00:01:47

Are you an athlete looking for a safe and effective way to increase your strength, stamina, lose body fat, and increase muscle mass? If so, you will surely find the results of the recently published SizeOn Maximum Performance study extremely valuable the next time you are supplement shopping! Lakewood, NJ (PRWEB) December 20, 2010 Gaspari Nutrition, a rapidly growing sports nutrition powerhouse, is proud to share with you the final published results of a nine-week 3rd party independent...

2010-12-20 00:00:38

Gaspari's SuperPump 250, a popular nutritional supplement, has been reformulated due to changes in the pre-workout market. Costa Mesa, CA (PRWEB) December 19, 2010 Gaspari Nutrition, a manufacturer of body building supplements, is releasing a reformulated version of SuperPump 250 called SuperPump Max this week. SuperPump 250 has been a popular nutritional supplement product for over 6 years but changes in the pre-workout market, particularly the popularity of "concentrates" have forced...

2010-12-15 00:00:44

Health Freedom Nutrition's new Citrulline A+â“ž¢ is a special blend of L-Citrulline and L-Arginine designed to boost nitric oxide levels both quickly and continuously. The secret lies in the fact that L-Citrulline acts as a precursor of L-Arginine in the body. Because L-Arginine increases the production of nitric oxide, Citrulline A+â“ž¢ works in a "time release" fashion to provide continuous nitric oxide production for people with...

2010-12-13 11:09:00

MIAMI, Dec. 13, 2010 /PRNewswire/ -- Top Secret Nutrition (TSN), a manufacturer, marketer and distributor of nutritional supplements announces today its entry into the sports supplement market with the debut of Astravar(TM) (Cellular Absorption Amplifier) and N.O.370 (Performance Enhancement Potentiator). Both products are based on Astragin, a new and exclusive ingredient that has been clinically tested to drastically increase the body's absorption of nutrients at the cellular level....

2010-11-15 07:00:00

BURLINGTON, Mass., Nov. 15, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes market in Mexico will grow to $1.22 billion in 2014. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market. "Mexico now has the largest type 2 diabetes population in the world behind the...

2010-11-04 08:24:30

(Ivanhoe Newswire) -- In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. In the past few years oseltamivir and zanamivir have been key drugs for limiting the impact of seasonal influenza both in individuals (by reducing morbidity and mortality) and collectively (by slowing the virus' spread to buy time for...

2010-11-04 01:05:46

In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. This key finding comes from a randomized, placebo-controlled trial"” in adults presenting with influenza symptoms at general practices throughout France during the seasonal influenza epidemic in 2008-2009"” carried out by Catherine Leport from...